Bristol Myers Squibb (BMY) EBT (2009 - 2026)
Bristol Myers Squibb (BMY) reported EBT of $4.09 billion for Q2 2026, up 130.5% from $1.77 billion a year earlier and up 26.1% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) EBT (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bristol Myers Squibb's EBT came in at $11.91 billion, up 80.6% year-over-year; for FY2025, it came in at $9.33 billion.
- By year, EBT came in at -$8.38 billion in FY2024, $8.44 billion in FY2023 (+9.4%), $7.71 billion in FY2022 (-4.8%) and $8.1 billion in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EBT in data going back to Q1 2009.
- Year over year, EBT has now increased in each of the last five quarters, with growth averaging 127.4% over the last seven quarters.
- The high point for year-over-year EBT in five years was Q4 2025 (growth of 740.0%); the low point was Q4 2024 (a decline of 89.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.24 billion (Q1 2026), $1.47 billion (Q4 2025) and $3.11 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Bristol Myers Squibb | 120.21 Bn | 71.48 Bn | 9.25 Bn | 4.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.09 Bn |
| Mar 31, 2026 | 3.24 Bn |
| Dec 31, 2025 | 1.47 Bn |
| Sep 30, 2025 | 3.11 Bn |
| Jun 30, 2025 | 1.77 Bn |
| Mar 31, 2025 | 2.97 Bn |
| Dec 31, 2024 | 175.00 Mn |
| Sep 30, 2024 | 1.68 Bn |
| Jun 30, 2024 | 1.29 Bn |
| Mar 31, 2024 | -11.52 Bn |
| Dec 31, 2023 | 1.67 Bn |
| Sep 30, 2023 | 2.14 Bn |
| Jun 30, 2023 | 1.86 Bn |
| Mar 31, 2023 | 2.77 Bn |
| Dec 31, 2022 | 1.86 Bn |
| Sep 30, 2022 | 2.21 Bn |
| Jun 30, 2022 | 1.96 Bn |
| Mar 31, 2022 | 1.69 Bn |
| Dec 31, 2021 | 1.86 Bn |
| Sep 30, 2021 | 2.16 Bn |
API Access
Bristol Myers Squibb EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();